PRIMPERAN 10 mg/2 ml, solution for injection in an ampoule 12 ampoules of 2 ml
Active ingredients: Metoclopramide hydrochloride, Metoclopramide hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection12 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRIMPERAN 10 mg/2 ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 12 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- MEDIPHA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Aug 1964
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61729093CIP73086166CIP133400930861660Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MÉTOCLOPRAMIDEsolution | 10,50 mg · une ampoule de 2 ml | SA |
| CHLORHYDRATE DE MÉTOCLOPRAMIDE ANHYDREsolution | 10,00 mg · une ampoule de 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.